February 17, 2014

PET scans identified predictors of outcome in patients with sarcomas

Fluorodeoxyglucose positron emission tomography helped determine the outcomes of chemotherapy treatment for patients with bone sarcomas.  “The utility of a tumor pre-therapy [fluorodeoxyglucose positron emission tomography] FDG PET scan as a biomarker for the outcome of patients with sarcoma was strengthened by a mid-therapy scan to evaluate the interim treatment response,” the investigators wrote. {read more here}